Literature DB >> 24959473

Experience with uroflowmetry in evaluation of lower urinary tract symptoms in patients with benign prostatic hyperplasia.

Sanjeev Singla1, Ramneesh Garg2, Ankit Singla3, Sandeep Sharma4, Jasdeep Singh5, Pulkit Sethi3.   

Abstract

INTRODUCTION: Uroflowmetry is a non- invasive urodynamic tool which is widely used for most of the patients with suspected lower urinary tract dysfunction. The severity of lower urinary tract symptoms (LUTS) can be measured reliably by using a number of validated questionnaires, like International Prostate Symptom Score (IPSS). This study was designed to determine the relationship between the parameters of uroflowmetry and symptom severity.
MATERIALS AND METHODS: Fifty patients with LUTS caused by benign prostatic hyperplasia were evaluated by using uroflowmetry, IPSS, prostate volume estimation. The correlations between these parameters were quantified by means of Spearman correlation co-efficients.
RESULTS: Statistically significant correlations were found between the IPSS and results of uroflowmetry (peak flow rate and average flow rate) and post void residual urine. No correlation was found between the IPSS and results of prostate volume measurements.
CONCLUSION: There was a positive correlation between peak flow rate, as was measured by uroflowmetry and lower urinary tract symptom severity.

Entities:  

Keywords:  Benign prostatic hyperplasia; Lower urinary tract symptoms; Uroflowmetry

Year:  2014        PMID: 24959473      PMCID: PMC4064883          DOI: 10.7860/JCDR/2014/7909.4271

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  15 in total

1.  Distribution of post-void residual urine volume in randomly selected men.

Authors:  C Kolman; C J Girman; S J Jacobsen; M M Lieber
Journal:  J Urol       Date:  1999-01       Impact factor: 7.450

2.  The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardisation Committee of the International Children's Continence Society.

Authors:  Tryggve Nevéus; Alexander von Gontard; Piet Hoebeke; Kelm Hjälmås; Stuart Bauer; Wendy Bower; Troels Munch Jørgensen; Søren Rittig; Johan Vande Walle; Chung-Kwong Yeung; Jens Christian Djurhuus
Journal:  J Urol       Date:  2006-07       Impact factor: 7.450

3.  The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume.

Authors:  J L Bosch; W C Hop; W J Kirkels; F H Schröder
Journal:  Br J Urol       Date:  1995-05

4.  Correlation between uroflowmetry, prostate volume, postvoid residue, and lower urinary tract symptoms as measured by the International Prostate Symptom Score.

Authors:  K Ezz el Din; L A Kiemeney; M J de Wildt; F M Debruyne; J J de la Rosette
Journal:  Urology       Date:  1996-09       Impact factor: 2.649

Review 5.  Uroflowmetry in elderly men.

Authors:  K M Jensen
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

6.  The use of prostatic intravesical protrusion correlated with uroflowmetry: a new method to measure obstruction in patients with LUTS due to BOO without using P/F studies.

Authors:  Mauro Dicuio; Giorgio Pomara; Stepan Vesely; Girolamo Morelli; Filippo Menchini Fabris; Valeria Ales; Jan-Erik Damber; Christer Dahlstrand
Journal:  Arch Ital Urol Androl       Date:  2005-03

7.  The relationship of the International Prostate Symptom Score and objective parameters for diagnosing bladder outlet obstruction. Part I: when statistics fail.

Authors:  B S Wadie; E H Ibrahim; J J de la Rosette; M A Gomha; M A Ghoneim
Journal:  J Urol       Date:  2001-01       Impact factor: 7.450

8.  Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms.

Authors:  Stepan Vesely; Tomas Knutson; Jan-Erik Damber; Mauro Dicuio; Christer Dahlstrand
Journal:  Scand J Urol Nephrol       Date:  2003

9.  Does sildenafil affect uroflowmetry values in men with lower urinary tract symptoms suggestive of benign prostatic enlargement?

Authors:  Cem Güler; Emre Tüzel; Engin Doğantekin; Güneş Kiziltepe
Journal:  Urol Int       Date:  2008-03-19       Impact factor: 2.089

10.  Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients.

Authors:  W K Mebust; H L Holtgrewe; A T Cockett; P C Peters
Journal:  J Urol       Date:  1989-02       Impact factor: 7.450

View more
  9 in total

1.  Clinical validation of an audio-based uroflowmetry application in adult males.

Authors:  Mark T Dawidek; Rohit Singla; Lucie Spooner; Louisa Ho; Christopher Nguan
Journal:  Can Urol Assoc J       Date:  2022-03       Impact factor: 1.862

2.  Changes in urination according to the sound of running water using a mobile phone application.

Authors:  Whi-An Kwon; Sung Han Kim; Sohee Kim; Jae Young Joung; Jinsoo Chung; Kang Hyun Lee; Sang-Jin Lee; Ho Kyung Seo
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

3.  The remote effects of intravitreal anti-VEGF therapy.

Authors:  F Balta; M Merticariu; C Taban; G Neculau; A Merticariu; D Muresanu; D Badescu; V Jinga
Journal:  J Med Life       Date:  2016 Oct-Dec

4.  Seasonal Changes in Lower Urinary Tract Symptoms in Japanese Men With Benign Prostatic Hyperplasia Treated With α1-Blockers.

Authors:  Minoru Kobayashi; Akinori Nukui; Takao Kamai
Journal:  Int Neurourol J       Date:  2017-09-12       Impact factor: 2.835

5.  Transperineal intraprostatic injection of botulinum neurotoxin A vs transurethral resection of prostate for management of lower urinary tract symptoms secondary to benign prostate hyperplasia: A prospective randomised study.

Authors:  Amr S El-Dakhakhny; Tarek Gharib; Ahmed Issam; Tarek M El-Karamany
Journal:  Arab J Urol       Date:  2019-10-03

6.  No Relationship Between the International Prostate Symptom Score and Post-Void Residual Volume in Primary Care.

Authors:  H A Lammers; T A M Teunissen; H Bor; I S Smid; A L M Lagro-Janssen
Journal:  Res Rep Urol       Date:  2020-05-05

7.  Reliability and validity of assessment methods available in primary care for bladder outlet obstruction and benign prostatic obstruction in men with lower urinary tract symptoms: a systematic review.

Authors:  Tom Vredeveld; Esther van Benten; Rikie E P M Beekmans; M Patrick Koops; Johannes C F Ket; Jurgen Mollema; Stephan P J Ramaekers; Jan J M Pool; Michel W Coppieters; Annelies L Pool-Goudzwaard
Journal:  BMJ Open       Date:  2022-04-29       Impact factor: 3.006

Review 8.  Botulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of Action.

Authors:  Jia-Fong Jhang; Hann-Chorng Kuo
Journal:  Toxins (Basel)       Date:  2016-04-21       Impact factor: 4.546

9.  Urethral meatus stricture BOO stimulates bladder smooth muscle cell proliferation and pyroptosis via IL‑1β and the SGK1‑NFAT2 signaling pathway.

Authors:  Wang Kai; Chen Lin; Yang Jin; He Ping-Lin; Liu Xun; Amend Bastian; Stenzl Arnulf; Xing Sha-Sha; Luo Xu; Cui Shu
Journal:  Mol Med Rep       Date:  2020-04-24       Impact factor: 2.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.